Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg
Clinical trial NCT00647634 · COMPLETED
Trial details
- NCT number
- NCT00647634
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2004-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.